Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a …
Background Multiple studies have provided evidence of suboptimal or poor immune
responses to SARS-CoV-2 vaccines in recipients of hematopoietic stem cell transplantation …
responses to SARS-CoV-2 vaccines in recipients of hematopoietic stem cell transplantation …
Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B-and T cell immunity in pediatric stem cell transplant recipients
LML Thole, L Tóth, V Proß, J Siegle, C Stahl… - Frontiers in …, 2023 - frontiersin.org
Stem cell transplant recipients (SCTR) are imperiled to increased risks after SARS-CoV2
infection, supporting the need for effective vaccination strategies for this vulnerable group …
infection, supporting the need for effective vaccination strategies for this vulnerable group …
SARS-CoV-2 Vaccine Non-response among Hematopoietic Stem Cell Transplant Patients: A Systematic Review and Meta-analysis
Background Hematopoietic stem cell transplant (HSCT) recipients are uniquely vulnerable
to adverse outcomes of SARS-CoV-2 infection. Small, mostly observational studies suggest …
to adverse outcomes of SARS-CoV-2 infection. Small, mostly observational studies suggest …